Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation

Journal of the American Society of Nephrology

Volumn 18, Issue 1, 2007, Pages 46-57

  Nguyen, Anh Nguyet T ^a   Wallace, Darren P ^a,b   Blanco, Gustavo ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OUABAIN;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 33845977762     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006010086     Document Type: Article

References (50)

1. Skou JC, Esmann M: The Na,K-ATPase. J Bioenerg Biomembr 24: 249-261, 1992
2. Feraille E, Doucet A: Sodium-potassium-adenosinetriphos-phatase-dependent sodium transport in the kidney: Hormonal control. Physiol Rev 81: 345-418, 2001
3. Blanco G: Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol 25: 292-303, 2005
4. Mobasheri A, Avila J, Cozar-Castellano I, Brownleader MD, Trevan M, Francis MJ, Lamb JF, Martin-Vasallo P: Na+,K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 20: 51-91, 2000
5. Sweadner KJ, Rael E: The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68: 41-56, 2000
6. Blaustein MP, Juhaszova M, Golovina VA: The cellular mechanism of action of cardiotonic steroids: A new hypothesis. Clin Exp Hypertens 20: 691-703, 1998
7. Wasserstrom JA, Aistrup GL: Digitalis: New actions for an old drug. Am J Physiol Heart Circ Physiol 289: H1781-H1793, 2005
8. Schoner W: Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269: 2440-2448, 2002
9. Allen JC, Abramowitz J, Koksoy A: Low concentrations of ouabain activate vascular smooth muscle cell proliferation. Ann N Y Acad Sci 986: 504-508, 2003
10. Chueh SC, Guh JH, Chen J, Lai MK, Teng CM: Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells. J Urol 166: 347-353, 2001
11. Kometiani P, Li J, Gnudi L, Kahn BB, Askari A, Xie Z: Multiple signal transduction pathways link Na+/K+-AT-Pase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem 273: 15249-15256, 1998
12. Mohammadi K, Liu L, Tian J, Kometiani P, Xie Z, Askari A: Positive inotropic effect of ouabain on isolated heart is accompanied by activation of signal pathways that link Na+/K+-ATPase to ERK1/2. J Cardiovasc Pharmacol 41: 609-614, 2004
13. Murata Y, Matsuda T, Tamada K, Hosoi R, Asano S, Takuma K, Tanaka K, Baba A: Ouabain-induced cell proliferation in cultured rat astrocytes. Jpn J Pharmacol 72: 347-353, 1996
14. Dmitrieva RI, Doris PA: Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells. J Biol Chem 278: 28160-28166, 2002
15. Xie Z, Cai T: Na+-K+-ATPase-mediated signal transduction: From protein interaction to cellular function. Mol Interv 3: 157-168, 2003
16. Sutters M, Germino GG: Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology. J Lab Clin Med 14: 91-101, 2003
17. Wilson PD: Polycystic kidney disease. N Engl J Med 350: 151-164, 2004
18. Ong AC, Harris PC: Molecular pathogenesis of ADPKD: The polycystin complex gets complex. Kidney Int 67:1234-1247, 2005
19. Murcia NS, Sweeney WE Jr, Avner ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55: 1187-1197, 1999
20. Al-Bhalal L, Akhtar M: Molecular basis of autosomal dominant polycystic kidney disease. Adv Anal Pathol 55: 126-133, 2005
21. Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM Jr, Grantham JJ: Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66: 964-973, 2004
22. Ye M, Grant M, Sharma M, Elzinga L, Swan S, Torres VE, Grantham JJ: Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J Am Soc Nephrol 3: 984-994, 1992
23. Sweeney WE Jr, Avner ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387-F394, 1998
24. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED: EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64: 1573-1579, 2003
25. Yamaguchi T, Felling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ: cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57: 1460-1471, 2000
26. Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Felling JC, Grantham JJ: Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63: 1983-1994, 2003
27. Sullivan LP, Wallace DP, Grantham JJ: Epithelial transport in polycystic kidney disease. Physiol Rev 78: 1165-1191, 1998
28. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, Grantham JJ: Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP. FASEB J 3: 2629-2632, 1989
29. Ye M, Grant M, Sharma M, Elzinga L, Swan S, Torres VE, Grantham JJ: Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J Am Soc Nephrol 4: 984-994, 1992
30. Wallace DP, Grantham JJ, Sullivan LP: Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 50: 1327-1336, 1996
31. Grindstaff KK, Blanco G, Mercer RW: Characterization of Na,K-ATPase isoform expression and activity in MDCK and Caco-2 epithelial cells. Epithelial Cell Biol 4:17-24, 1995
32. Neufeld TK, Douglass D, Grant M, Ye M, Silva F, Nadasdy T, Grantham JJ: In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41: 1222-1236, 1992
33. Wagoner K, Sanchez G, Nguyen AN, Enders GC, Blanco G: Different expression and activity of the alphal and alpha4 isoforms of the Na,K-ATPase during rat male germ cell ontogeny. Reproduction 130: 627-641, 2005
34. Arystarkhova E, Donnet C, Asinovski NK, Sweadner KJ: Differential regulation of renal Na,K-ATPase by splice variants of the gamma subunit. J Biol Chem 277: 10162-10172, 2002
35. Marshall NJ, Goodwin CJ, Holt SJ: A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5: 69-84, 1995
36. Blanco G, Sanchez G, Mercer RW: Comparison of the enzymatic properties of the Na,K-ATPase alpha3beta1 and alpha3beta2 isozymes. Biochem 34: 9897-9903, 1995
37. Wang J, Velotta JB, McDonough AA, Farley RA: All human Na,K-ATPase alpha subunit isoforms have a similar affinity for cardiac glycosides. Am J Physiol 281: C1336-C1343, 2001
38. Li J, Zelenin S, Aperia A, Aizman O: Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol 17: 1848-1857, 2006
39. Wilson PD, Devuyst O, Li X, Gatti L, Falkenstein D, Robinson S, Fambrough D, Burrow CR: Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the beta2 isoform. Am J Pathol 156: 253-268, 2000
40. Pagel P, Zatti A, Kimura T, Duffield A, Chauvet V, Rajendran V, Caplan MJ: Ion pump-interacting proteins: Promising new partners. Ann N Y Acad Sci 986: 360-368, 2003
41. Zatti A, Chauvet V, Rajendran V, Kimura T, Pagel P, Caplan MJ: The C-terminal tail of the polycystin-1 protein interacts with the Na,K-ATPase alpha-subunit. Mol Biol Cell 16: 5087-5093, 2005
42. Blanco G: The Na,K-ATPase and its isozymes: What we have learned using the baculovirus expression system. Front Biosci 10: 2397-2411, 2005
43. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet J: Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279: 40419-40430, 2004
44. Levin ER: Cellular functions of plasma membrane estrogen receptors. Steroids 67: 471-475, 2002
45. Korovkina VP, Brainard AM, Ismail P, Schmidt TJ, England SK: Estradiol binding to maxi-K channels induces their down-regulation via proteasomal degradation. J Biol Chem 279: 1217-1223, 2004
46. Haseroth K, Christ M, Falkenstein E, Wehling M: Aldosterone- and progesterone-membrane-binding proteins: New concepts of nongenomic steroid action. Curr Protein Pept Sci 1: 385-401, 2000
47. Noel F, Fagoo M, Godfraind T: A comparison of the affinities of rat (Na+ + K+)-ATPase isozymes for cardioactive steroids, role of lactone ring, sugar moiety and KCl concentration. Biochem Pharmacol 40: 2611-2616, 1990
48. Cowley BD Jr, Rupp JC, Muessel MJ, Gattone VH 2nd: Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Am J Kidney Dis 29: 265-272, 1997
49. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S: Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68: 1729-1739, 2005
50. Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E, Bianchi G, Ferrari P: Ouabain antagonists as antihypertensive agents. Curr Pharm Des 1: 3301-3305, 2005